VERA Financial Facts
Product revenues: 280KSelling, general and administrative: 1.89M
See Full Income Statement
Other accrued liabilities: 1.49M
Investments: 116.83K
See Full Balance Sheet
Vera Therapeutics, Inc. (VERA) Earnings
|
Expand Research on VERA
| Next EPS Date | 8/6/26 | EPS Growth Rate | -35.0% |
|---|---|---|---|
| Average EPS % Beat Rate | -23.4% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +8.8% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/6/26  |
Q226 | N/A | -$1.62 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/7/26 | Q126 | -$1.69 | -$1.33 | -$0.36 | N/A | N/A | N/A |  | | Details | |
| 3/19/26 |
Q425 | N/A | -$1.28 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/5/25 | Q325 | -$1.26 | -$1.15 | -$0.11 | N/A | N/A | N/A | | | Details | |
| 8/5/25 |
Q225 | -$1.20 | -$0.82 | -$0.38 | N/A | N/A | N/A | | | Details | |
| 5/6/25 |
Q125 | N/A | -$0.73 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/20/25 |
Q424 | N/A | -$0.81 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/7/24 |
Q324 | N/A | -$0.64 | N/A | N/A | N/A | N/A | N/A | N/A |
